These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28446459)

  • 1. Distinct roles of arginases 1 and 2 in diabetic nephropathy.
    Morris SM; You H; Gao T; Vacher J; Cooper TK; Awad AS
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F899-F905. PubMed ID: 28446459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism.
    You H; Gao T; Cooper TK; Morris SM; Awad AS
    Kidney Int; 2013 Dec; 84(6):1189-97. PubMed ID: 23760286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase-2 mediates diabetic renal injury.
    Morris SM; Gao T; Cooper TK; Kepka-Lenhart D; Awad AS
    Diabetes; 2011 Nov; 60(11):3015-22. PubMed ID: 21926276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy.
    You H; Gao T; Cooper TK; Morris SM; Awad AS
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F447-55. PubMed ID: 26041444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation.
    You H; Gao T; Cooper TK; Morris SM; Awad AS
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1292-301. PubMed ID: 25320354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.
    Awad AS; You H; Gao T; Cooper TK; Nedospasov SA; Vacher J; Wilkinson PF; Farrell FX; Brian Reeves W
    Kidney Int; 2015 Oct; 88(4):722-33. PubMed ID: 26061548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginase-1 Is Required for Macrophage-Mediated Renal Tubule Regeneration.
    Shin NS; Marlier A; Xu L; Doilicho N; Linberg D; Guo J; Cantley LG
    J Am Soc Nephrol; 2022 Jun; 33(6):1077-1086. PubMed ID: 35577558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells.
    Lee SE; Jang JE; Kim HS; Jung MK; Ko MS; Kim MO; Park HS; Oh W; Choi SJ; Jin HJ; Kim SY; Kim YJ; Kim SW; Kim MK; Sung CO; Pack CG; Lee KU; Koh EH
    Exp Mol Med; 2019 Jul; 51(7):1-14. PubMed ID: 31285429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury.
    Awad AS; Kinsey GR; Khutsishvili K; Gao T; Bolton WK; Okusa MD
    Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1358-66. PubMed ID: 21880831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.
    Haydar D; Gonzalez R; Garvy BA; Garneau-Tsodikova S; Thamban Chandrika N; Bocklage TJ; Feola DJ
    Immunobiology; 2021 Jan; 226(1):152034. PubMed ID: 33278710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
    Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
    Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase-2 mediates renal ischemia-reperfusion injury.
    Raup-Konsavage WM; Gao T; Cooper TK; Morris SM; Reeves WB; Awad AS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F522-F534. PubMed ID: 28515179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy.
    Ito S; Nakashima H; Ishikiriyama T; Nakashima M; Yamagata A; Imakiire T; Kinoshita M; Seki S; Kumagai H; Oshima N
    Am J Physiol Renal Physiol; 2021 Dec; 321(6):F757-F770. PubMed ID: 34719947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
    Navarro JF; Milena FJ; Mora C; León C; García J
    Am J Nephrol; 2006; 26(6):562-70. PubMed ID: 17167242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy.
    Wang X; Yao B; Wang Y; Fan X; Wang S; Niu A; Yang H; Fogo A; Zhang MZ; Harris RC
    Diabetes; 2017 Feb; 66(2):494-504. PubMed ID: 27815317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
    Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
    Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
    Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.